Chemistry & Biodiversity · 2005 · 24 citations · 12 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryStructure-activity RelationshipsEicosanoid BiosynthesisEnzyme InhibitionStructure-activity Relationship AnalysisBioassay-guided FractionationCyclooxygenase InhibitorsCyclooxygenase PathwaysCyclooxygenase-2 PathwayKetonesProstaglandin Biosynthesis InhibitorsSelective Cyclooxygenase-2 Inhibitors
1-[2,4-Dihydroxy-6-methoxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]ethanone (1), and a new aryl ketone, named acrovestenol (2), were isolated as cyclooxygenase-2 (COX-2) inhibitory principles from a CH2Cl2 extract of the bark of Acronychia pedunculata by a bioassay-guided fractionation procedure. Compound 2 inhibited COX-2 with an IC50 value of 142.0+/-2.15 microM, compared to the COX-2 inhibitory reference compound NS-398 with an IC50 value of 11.3+/-1.12 microM. Compound 1 inhibited COX-2-catalyzed PG biosynthesis with 68% at a concentration of 500 microM. The structures were determined by UV, IR, and 1D- and 2D-NMR, including TOCSY, HSQC-DEPT, and HMBC, and MS investigations.
12
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Robert A. Soslow, Andrew J. Dannenberg, Demaretta Rush et al. · Cancer · 2000 · 872 citations
Ylva Noreen, Therese Ringbom, Premila Perera et al. · Journal of Natural Products · 1998 · 122 citations · Full text
Acetophenone Derivatives from <i>Acronychia </i><i>p</i><i>edunculata</i>
Chung-Ren Su, Ping‐Chung Kuo, Meei-Ling Wang et al. · Journal of Natural Products · 2003 · 63 citations · Full text